Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 12 July, 2018

Euronext Dublin

GEM Notice

RNS Number : 5138U
Euronext Dublin
12 July 2018
 

 

EURONEXT DUBLIN

 

 

 

 

ADMISSION NOTICE

 

                                   

Euronext Dublin

28 Anglesea Street

Dublin 2

 

 

12th July 2018

 

Euronext Dublin approves the admission of the undermentioned securities to listing on the Official List and trading on the Global Exchange Market.

 

 

CBAM 2018-6, LTD.

 

USD 40,000,000 Class E Deferrable Floating Rate Notes due 2031 (144A) US12482AAA79

USD 92,000,000 Class B-1 Floating Rate Notes due 2031 (144A) US12481XAE04

USD 85,300,000 Subordinated Notes due 2031 (Reg S) USG20107AB74

USD 18,000,000 Class B-2 Floating Rate Notes due 2031 (Reg S) USG2010GAD37

USD 60,000,000 Class D Deferrable Floating Rate Notes due 2031 (Reg S) USG2010GAF84

USD 60,000,000 Class C Deferrable Floating Rate Notes due 2031 (Reg S) USG2010GAE10

USD 92,000,000 Class B-1 Floating Rate Notes due 2031 (Reg S) USG2010GAC53

USD 60,000,000 Class D Deferrable Floating Rate Notes due 2031 (144A) US12481XAL47

USD 40,000,000 Class E Deferrable Floating Rate Notes due 2031 (Reg S) USG20107AA91

USD 85,300,000 Subordinated Notes due 2031 (144A) US12482AAC36

USD 18,000,000 Class B-2 Floating Rate Notes due 2031 (144A) US12481XAG51

USD 650,000,000 Class A Floating Rate Notes due 2031 (Reg S) USG2010GAB70

USD 650,000,000 Class A Floating Rate Notes due 2031 (144A) US12481XAC48

USD 60,000,000 Class C Deferrable Floating Rate Notes due 2031 (144A) US12481XAJ90

 

Debt Security

 

This announcement has been issued through the Companies Announcement Service of

Euronext Dublin.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEQLLFFVDFFBBL

a d v e r t i s e m e n t